Delivery Order SPE2DB20D2104-SPE2DB22FT51G
Award Date 8/3/22
Potential Completion Date 8/4/22
Potential Value $9.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,893.39, is for the delivery of Restasis 0.05% Eye Emulsion medical product. The award is a delivery order with a firm fixed price. The contract has an ultimate completion date of May 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,628.38 delivery order contract is for the supply of Restasis 0.05% eye emulsion 60s, a specialty pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,046.52 firm fixed-price delivery order is for the supply of Restasis 0.05% eye emulsion, a specialty ophthalmic medication. The contract has a performance period ending on July 27, 2022 and was awarded on July 26, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,537.07 firm fixed-price delivery order is for the supply of Restasis 0.05% eye emulsion, a prescription medication used to treat dry eye disease. The contract has an ultimate completion date of November 3, 2021 and was awarded on November 2, 2021. This delivery order is part of a larger $999,999,999 Indefinite...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion 60s to the Defense Logistics Agency (DLA). The contract, valued at $11,657.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has a completion date of May 3, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $2,446.44, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order type, with a Firm Fixed Price pricing structure, and has an ultimate completion date of January 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $75,167.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Restasis 0.05% eye emulsion, a prescription eye medication, to support military healthcare programs. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,695.65, is for the delivery of Restasis 0.05% Eye Emulsion in 60-count packs. The contract has a firm fixed-price pricing type and an ultimate completion date of December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
- This federal contract award, valued at $6,319.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Restasis 0.05% eye emulsion, a prescription eye medication. The award was made as a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,091.34 firm fixed-price contract is for the delivery of Restasis 0.05% eye emulsion 30s, a specialty pharmaceutical product. The contract has a completion date of February 10, 2023 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...